Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
(STDs) and is frequently presented clinically as anogenital warts in both males and females …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …

Objectives To compare the effect and cost effectiveness of bivalent and quadrivalent human
papillomavirus (HPV) vaccination, taking into account differences in licensure indications …

Objective The goal of this study was to review the current human papillomavirus (HPV)
vaccine program and its outcomes to date in Australia. Methods This was a review of the …

Objectives To evaluate the prophylactic efficacy of the human papillomavirus (HPV)
quadrivalent vaccine in preventing low grade cervical, vulvar, and vaginal intraepithelial …

Abstract Background. Public Health England has reported a decrease of up to 20.8% in new
diagnoses of external genital warts (GWs) among women aged< 19 years since the national …

Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …

Background The quadrivalent human papillomavirus (HPV) vaccine was shown to prevent
infections and lesions related to HPV6, 11, 16, and 18 in a randomised, placebo-controlled …

Abstract Background. In April 2009, experts on sexually transmitted diseases (STDs) were
convened to review updates on STD prevention and treatment in preparation for the revision …

This quadrivalent human papillomavirus (qHPV)(HPV6,-11,-16, and-18) vaccine long-term
follow-up (LTFU) study is an ongoing extension of a pivotal clinical study (FUTURE II) taking …